The evaluation of Hertia cheirifolia L. extract by GC-MS coupled with in silico study as potent inhibitors of human pancreatic lipase

Keyphrases

• Aerial Parts 33%
• Anti-obesity 66%
• Biological Activity 33%
• Carcinogenic Activity 33%
• Cardiovascular Risk 33%
• Crude Extract 33%
• Cytotoxicity Profile 33%
• Diarrhea 33%
• Dynamic Study 33%
• Enzyme Inhibition 33%
• Gas Chromatography-mass Spectrometry 100%
• Hemorrhoids 33%
• Hertia Cheirifolia 100%
• Hexane 33%
• Hydroalcoholic 33%
• In Silico Methods 33%
• In Silico Study 100%
• Long History 33%
• Maceration 33%
• Natural Sources 33%
• Orlistat 33%
• PASS Prediction 33%
• Porcine Pancreatic Lipase 100%
• Potent Inhibitor 100%
• Risky Behavior 33%
• Stomachache 33%
• Therapeutic Use 33%
• Traditional Uses 33%

Medicine and Dentistry

• Antiobesity Drugs 66%
• Carcinogenic Activity 33%
• Cardiovascular Risk 33%
• Cytotoxicity 33%
• Diarrhea 33%
• Enzyme Inhibition 33%
• Gas Chromatography Mass Spectrometry 100%
• Hemorrhoid 33%
• Hexane 33%
• In Silico 100%
• Triacylglycerol Lipase 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiobesity Drugs 66%
• Cardiovascular Risk 33%
• Cytotoxicity 33%
• Diarrhea 33%
• Enzyme Inhibition 33%
• Hemorrhoid 33%
• Hexane 33%
• Pancreatic Lipase 100%
• Tetrahydrolipstatin 33%